Continuting Education

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the International Society for Bipolar Disorders.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME)

Credit Designation Statement –  Amedco LLC designates this live activity for a maximum of 51.00 AMA PRA Category 1 CreditsTM.

Physicians should claim only the credit commensurate with the extent of their participation in the activity. Some sessions are live virtual and also recorded, however, you can only claim credit for any given session once.

Learning Objectives

  • After attending this conference, attendees will have a further understanding of the use of digital technology to improve diagnosis and treatment of bipolar disorder.
  • Attendees will gain a better understanding of of the association between the microbiome, stress and bipolar disorder.
  • Attendees will gain an update as to the latest pharmacology and non-pharmacological treatment approaches.
  • After attending this conference, attendees will have an appreciation for controversies including pediatric bipolar disorder, staging of bipolar disorders and differentiation between bipolar and unipolar major depression.
  • Attendees will be able to discuss the latest research into biomarkers and biological origins of disease in mood disorders.
  • Attendees will gain an appreciation of treatment of bipolar disorders from those with lived experience.

Target Audience

The target audience for this conference is physicians and researchers in the mental health field that specialize in bipolar disorder and depression.